No Data
No Data
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024
Sight Sciences Reports Publication Of New Study Titled, Impact Of TearCare On Reading Speed In Patients With Dry Eye Disease In The Peer-reviewed Journal Clinical Ophthalmology
Single TearCare Treatment Improved Functional Visual Outcomes as Well as Signs and Symptoms of Patients With Dry Eye Disease in Investigator-Initiated Trial
Don't Ignore The Insider Selling In Sight Sciences
Institutional Investors Own a Significant Stake of 34% in Sight Sciences, Inc. (NASDAQ:SGHT)
Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $10